PEOPLE

Karen S. Gustafson, MD, PhD

Associate Professor of Clinical Pathology and Laboratory Medicine
University of Pennsylvania Perelman School of Medicine

Contact InformationUniversity of Pennsylvania Medical Center
6 Founders, Room FO6.042
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-662-3209

Email: Karen.Gustafson@uphs.upenn.edu

Specialty Division

Anatomic Pathology

Education

B.A. (Biology and Chemistry), Gustavus Adolphus College, 1983
MD, PhD (Biomedical Science), University of Minnesota Medical Scientist Training Program, 1998

Specialty Certification

American Board of Pathology, Anatomic and Clinical Pathology, 2002
American Board of Pathology, Cytopathology, 2004
American Board of Pathology, Recertification, 2014

Postgraduate Training

Intern, Anatomic and Clinical Pathology, Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 1998-1999
Resident, Anatomic and Clinical Pathology, Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 1999-2002
Chief Resident- Anatomic Pathology, Hospital of the University of Pennsylvania, 2001-2002
Fellow, Surgical Pathology, Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 2002-2003
Cytopatholgy Fellow, Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 2003-2004

Awards and Honors

Phi Beta Kappa, Gustavus Adolphus College, 1983
Phi Kappa Phi, University of Minnesota, 1994
Alpha Omega Alpha, University of Minnesota Medical School, 1997
J. Jacob Kaplan Award, University of Minnesota Medical School, 1997
H.T. Enterline Fellowship in Surgical Pathology Award, Hospital of the University of Pennsylvania, 2003
Geno Saccomanno, M.D. New Frontiers in Cytology Award, American Society of Cytopathology, 2009
Leadership Forum Excellence Recognition Award, Fox Chase Cancer Center, 2012

Memberships and Professional Organizations

College of American Pathologists, 2000 - Present
United States and Canadian Academy of Pathology, 2000 - Present
American Society of Clinical Pathologists, 2000 - 2004
Papanicolaou Society of Cytopathology, 2002 - Present
American Society of Cytopathology, 2003 - Present
American Society of Cytopathology, 2007 - 2008
American Society of Cytopathology, 2008 - 2010
Association for Molecular Pathology, 2010 - Present

Web Links


Selected Publications

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: A Fox Chase Cancer Center pilot study.

Vijayvergia, N., Boland, P. M., Handorf, E., Gustafson, K. S., Gong, Y., Cooper, H. S., Sheriff, F., Astsaturov, I. A., Cohen, S. J., Engstrom, P. F., Br. J. Cancer. 115(5): 564-570, 2016, PMID:27482646

Read article

Molecular profiling and clinical outcomes in patients with in-transit recurrence of melanoma.

Farma, J., Kulkarni, N., Escalante, D.A., Meade, C., Osevala, N., Zibelman, M., Gustafson, K.S., Wu, H., Lango, M., Reddy, S., Movva, S., Olszanski, A.J., Zih, F.S., Ann. Surg. Oncol. 23(): , 2016

Molecular profiling defines subsets of neuroendocrine tumors (NETs) with aggressive disease: A Fox Chase Cancer Center (FCCC) study.

Vijayvergia, N., Cohen, S.J., Boland, P.M., Gustafson, K.S., Sherrif, F., Cooper, H., Astaturov, I., Engstrom, P.F., Pancreas 45(3): 469-470, 2016

Tumor genomic profiling (TGP) in metastatic colorectal cancer (CRC): Bridging the community and the tertiary cancer center through genomic consultation (GC).

Kaczmar, J.M., Gustafson, K.S., Wong, Y.N., Minniti, C.J., Sandilya, V.K., Sprandio, J.D., Chertock, Y., Hart, C., Hall, M.J., J. of Clin. Oncol. 34(4): , 2016

Molecular profiling and clinical outcomes in malignant melanoma: Experience at a NCI-designated cancer center.

Zih, F.S., Kulkarni, N., Escalante, D.A., Meade, C., Osevala, N., Zibelman, M., Movva, S., Gustafson, K.S., Wu, H., Reddy, S., Lango, M., Olszanski, A.J., Farma, J., Ann. Surg. Oncol. 23(): , 2016

CSI: Cancer Signature Investigation: ERBB2 (HER2)-activating mutation and amplification-positive breast carcinoma mimicking lung primary.

Shih J, Bashir B, Gustafson KS, Andrake MA, Dunbrack RL, Goldstein LJ, Boumber Y., J. Natl. Compr. Canc. Netw, 2015

Molecular profiling of neuroendocrine tumors (NETs): The Fox Chase Cancer Center (FCCC) experience.

Vijayvergia, N., Boland, P. M., Cohen, S. J., Gustafson, K. S., Cooper, H. S., Astsaturov, I. A., Engstrom, P. F., J. of Clin. Oncol. 33(3): , 2015

Molecular markers in malignant melanoma: Experience at an NCI-designated cancer center.

Zibelman, M. R., Kulkarni, N., Lango, M., von Mehren, M., Movva, S., Gustafson, K. S., Reddy, S. S., Wu, H., Farma, J. M., Olszanski, A. J., J. of Clin. Oncol. 33(15): , 2015

A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.

Matthew, E.M., Zhou, L.L., Vijayvergia, N., Dicker, D.T., Gustafson, K.S., Cooper, H.S., Ross, E.A., Lim, B., Harouaka, R., Zheng, S.Y., Lamparella, N.E., Drabick, J.J., Truica, C.I., Yang, Z.H., El-Deiry, W.S., Cancer Res. 75(): , 2015

Molecular profiling of advanced stage neuro endocrine tumors (NETs): The Fox Chase Cancer Center (FCCC) experience.

Vijayvergia, N., Boland, P. M., Gustafson, K. S., Sheriff, F., Cooper, H. S., Cohen, S. J., Astsaturov, I. A., Engstrom, P. F., Pancreas 44(2): , 2015